{"ticker": {"uuid": "8b9e2fd1-7b49-4e63-9b67-ac70fcb5ec6f", "symbol": "300147", "name": "Xiangxue Pharmaceutical Co.,Ltd.", "exchange": "SHZ", "country": "CN", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Quick Take: China\u2019s Xiangxue Partners With U.S. Firm for Cancer Therapy", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNSnRjTnJubTJ3dm9MWlo1eXpMSHRWbWtOaDVVblczZTB0ZHRCcUdseDhoVmVIN1F1VzVVSWhhZUlCdDVxNDM0SHhaakFKUTk4RzJLWmI2T1BCTmFocDROaTN2VXk4eERheWFtcHItSjduVjNyZ1d0TlBEazQ3bEtJX1FCQ1FHZ2RndXVWQVBSUTJYd2JaOFF0dXRaaVZWRUpjZXcxQ3BocF8tS3o3ckZ3cHJLMHp6RlRKOWlsRlphWQ?oc=5", "source_name": "Caixin Global", "published_at": "2018-07-04T07:00:00+00:00", "published_display": "04 Jul 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Quick Take: China\u2019s Xiangxue Partners With U.S. Firm for Cancer Therapy", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNSnRjTnJubTJ3dm9MWlo1eXpMSHRWbWtOaDVVblczZTB0ZHRCcUdseDhoVmVIN1F1VzVVSWhhZUlCdDVxNDM0SHhaakFKUTk4RzJLWmI2T1BCTmFocDROaTN2VXk4eERheWFtcHItSjduVjNyZ1d0TlBEazQ3bEtJX1FCQ1FHZ2RndXVWQVBSUTJYd2JaOFF0dXRaaVZWRUpjZXcxQ3BocF8tS3o3ckZ3cHJLMHp6RlRKOWlsRlphWQ?oc=5", "source_name": "Caixin Global", "published_at": "2018-07-04T07:00:00+00:00", "published_display": "04 Jul 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 52, "total_relevant": 1, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 1, "score": 50, "total": 1, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 72, "events": [{"event": "general", "label": "Market update", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 6.42, "latest_week": "2026-07-17", "one_week_move": -30.0, "four_week_move": -35.2, "twelve_week_move": -36.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.859843, "market_dynamics_buy_signal": false, "relative_strength": -34.10823, "fair_value_gap": -16.8, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 50.9131, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-30.0% over one week, -35.2% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 55, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Caixin Global", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 1}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "72/100 classification confidence."}, {"label": "Company focus", "value": "1", "tone": "neutral", "text": "directly relevant article"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-30.0% over one week, -35.2% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Quick Take: China\u2019s Xiangxue Partners With U.S. Firm for Cancer Therapy"}], "updated_at": "2026-07-23T05:29:47.960311+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}